A Consumer’s Guide to Eggs

EDIS ◽  
2013 ◽  
Vol 2013 (11) ◽  
Author(s):  
Jeanine Beatty ◽  
Karla Shelnutt ◽  
Gail P. A. Kauwell

People have been eating eggs for centuries. Records as far back as 1400 BC show that the Chinese and Egyptians raised birds for their eggs. The first domesticated birds to reach the Americas arrived in 1493 on Christopher Columbus' second voyage to the New World. Most food stores in the United States offer many varieties of chicken eggs to choose from — white, brown, organic, cage free, vegetarian, omega-3 fatty acid enriched, and more. The bottom line is that buying eggs is not as simple as it used to be because more choices exist today. This 4-page fact sheet will help you understand the choices you have as a consumer, so you can determine which variety of egg suits you and your family best. Written by Jeanine Beatty, Karla Shelnutt, and Gail Kauwell, and published by the UF Department of Family Youth and Community Sciences, November 2013. http://edis.ifas.ufl.edu/fy1357

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
Kimberly Heidal ◽  
Robert C Hickner ◽  
Charles J Tanner ◽  
Patricia Brophy ◽  
Brian Schmitt ◽  
...  

2011 ◽  
Vol 27 (5) ◽  
pp. 541 ◽  
Author(s):  
Brenda Lee Simas PORTO ◽  
Marcus Vinicius Nora de SOUZA ◽  
Marcone Augusto Leal de OLIVEIRA

1990 ◽  
Vol 38 (3) ◽  
pp. 743-747 ◽  
Author(s):  
Zhibin Huang ◽  
Henry Leibovitz ◽  
Chong M. Lee ◽  
Richard Millar

2018 ◽  
Author(s):  
Rohan Khera ◽  
Javier Valero-Elizondo ◽  
Anshul Saxena ◽  
Salim S Virani ◽  
Harlan M Krumholz ◽  
...  

ABSTRACTIcosapent ethyl, an omega-3-fatty acid, was associated with improved cardiovascular outcomes in individuals with elevated levels of serum triglycerides and at a high-risk of adverse cardiovascular events in the recently completed REDUCE-IT trial. We applied the eligibility criteria of the REDUCE-IT trial to a nationally representative sample of individuals in the United States captured in the National Health and Nutrition Examination Survey (NHANES) for a 6-year period (2009-2014) and estimated the number of individuals nationally that would be potentially eligible for treatment with icosapentyl ethyl. We found that nearly 3 million US adults would potentially be candidates for this therapy. Further, based on the list cost of the drug, if all eligible individuals are treated, the additional cost to the US healthcare system will be almost $9 billion a year.


Sign in / Sign up

Export Citation Format

Share Document